117
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Development of invaethosomes and invaflexosomes for dermal delivery of clotrimazole: optimization, characterization and antifungal activity

, , , , &
Pages 611-624 | Received 17 Apr 2023, Accepted 20 Jun 2023, Published online: 18 Jul 2023

References

  • Ahmed OAA, Badr-Eldin SM. 2019. Development of an optimized avanafil-loaded invasomal transdermal film: ex vivo skin permeation and in vivo evaluation. Int J Pharm. 570:118657. doi: 10.1016/j.ijpharm.2019.118657.
  • Ammar HO, Tadros MI, Salama NM, Ghoneim AM. 2020. Ethosome-derived invasomes as a potential transdermal delivery system for vardenafil hydrochloride: development, optimization and application of physiologically based pharmacokinetic modeling in adults and geriatrics. Int J Nanomedicine. 15:5671–5685. doi: 10.2147/IJN.S261764.
  • Bhattacharya S. 2021. Central composite design for response surface methodology and its application in pharmacy. In: Kayaroganam P, editor. Response surface methodology in engineering science. London: IntechOpen.
  • Bnyan R, Cesarini L, Khan I, Roberts M, Ehtezazi T. 2020. The effect of ethanol evaporation on the properties of inkjet produced liposomes. Daru. 28(1):271–280. doi: 10.1007/s40199-020-00340-1.
  • Borhade V, Pathak S, Sharma S, Patravale V. 2012. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. Int J Pharm. 431(1–2):138–148. doi: 10.1016/j.ijpharm.2011.12.040.
  • Cevc G, Schätzlein A, Richardsen H. 2002. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 1564(1):21–30. doi: 10.1016/s0005-2736(02)00401-7.
  • Chen M, Liu X, Fahr A. 2010. Skin delivery of ferulic acid from different vesicular systems. J Biomed Nanotechnol. 6(5):577–585. doi: 10.1166/jbn.2010.1154.
  • Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10(2):57. doi: 10.3390/pharmaceutics10020057.
  • Dragicevic-Curic N, Gräfe S, Albrecht V, Fahr A. 2008. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. J Photochem Photobiol B. 91(1):41–50. doi: 10.1016/j.jphotobiol.2008.01.009.
  • Dragicevic-Curic N, Gräfe S, Gitter B, Winter S, Fahr A. 2010. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm. 384(1–2):100–108. doi: 10.1016/j.ijpharm.2009.10.006.
  • Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. 2008. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release. 127(1):59–69. doi: 10.1016/j.jconrel.2007.12.013.
  • Duangjit S, Nimcharoenwan T, Chomya N, Locharoenrat N, Ngawhirunpat T. 2017. Computational design strategy: an approach to enhancing the transdermal delivery of optimal capsaicin-loaded transinvasomes. Drug Dev Ind Pharm. 43(1):98–107. doi: 10.1080/03639045.2016.1220575.
  • Duangjit S, Obata Y, Sano H, Kikuchi S, Onuki Y, Opanasopit P, Ngawhirunpat T, Maitani Y, Takayama K. 2012. Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization. Biol Pharm Bull. 35(10):1720–1728. doi: 10.1248/bpb.b12-00343.
  • Duangjit S, Rattanachithawat N, Opanasopit P, Ngawhirunpat T. 2022. Development and optimization of finasteride-cinnamon oil-loaded ethanol-free microemulsions for transdermal delivery. J Drug Deliv Sci Technol. 69:103107. doi: 10.1016/j.jddst.2022.103107.
  • El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. 2018. Dapsone-loaded invasomes as a potential treatment of acne: preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech. 19(5):2174–2184. doi: 10.1208/s12249-018-1025-0.
  • Franzè S, Selmin F, Rocco P, Colombo G, Casiraghi A, Cilurzo F. 2020. Preserving the integrity of liposomes prepared by ethanol injection upon freeze-drying: insights from combined molecular dynamics simulations and experimental data. Pharmaceutics. 12(6):530. doi: 10.3390/pharmaceutics12060530.
  • Gomez-Lopez A, Aberkane A, Petrikkou E, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. 2005. Analysis of the influence of tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp. J Clin Microbiol. 43(3):1251–1255. doi: 10.1128/JCM.43.3.1251-1255.2005.
  • Honary S, Zahir F. 2013. Effect of zeta potential on the properties of nano-drug delivery systems – a review (Part 2). Trop J Pharm Res. 12(2):255–264. doi: 10.4314/tjpr.v12i2.19.
  • Iqbal DN, Ashraf A, Iqbal M, Nazir A. 2020. Analytical method development and validation of hydrocortisone and clotrimazole in topical dosage form using RP-HPLC. Futur J Pharm Sci. 6(1):49. doi: 10.1186/s43094-020-00065-7.
  • Kikuchi S, Takayama K. 2010. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug. Int J Pharm. 386(1–2):149–155. doi: 10.1016/j.ijpharm.2009.11.008.
  • Mishra KK, Kaur CD, Verma S, Kumar Sahu A, Kumar Dash D, Kashyap P, Mishra SP. 2019. Transethosomes and nanoethosomes: recent approach on transdermal drug delivery system. In: Farrukh MA, editor. Nanomedicines. London: IntechOpen.
  • Lombardo D, Kiselev MA. 2022. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 14(3):543. doi: 10.3390/pharmaceutics14030543.
  • Maheshwari RGS, Tekade RK, Sharma PA, Darwhekar G, Tyagi A, Patel RP, Jain DK. 2012. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J. 20(2):161–170. doi: 10.1016/j.jsps.2011.10.001.
  • Mizushima H, Fukasawa J, Suzuki T. 1996. Phase behavior of artificial stratum corneum lipids containing a synthetic pseudo-ceramide: a study of the function of cholesterol. J Lipid Res. 37(2):361–367. doi: 10.1016/S0022-2275(20)37622-7.
  • Moghimi HR, Shirazi FH, Shafiee Ardestani M, Oghabian MA, Saffari M, Sojoudi J. 2015. In vitro and in vivo enhancement of antitumoral activity of liposomal antisense oligonucleotides by cineole as a chemical penetration enhancer. J Nanomater. 2015:1–10. doi: 10.1155/2015/967473.
  • Muñoz JE, Rossi DCP, Jabes DL, Barbosa DA, Cunha FFM, Nunes LR, Arruda DC, Pelleschi Taborda C. 2020. In vitro and in vivo inhibitory activity of limonene against different isolates of candida spp. J Fungi. 6(3):183. doi: 10.3390/jof6030183.
  • Mura S, Manconi M, Fadda AM, Sala MC, Perricci J, Pini E, Sinico C. 2013. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy. Pharm Dev Technol. 18(6):1339–1345. doi: 10.3109/10837450.2012.685661.
  • Nair RS, Billa N, Leong C-O, Morris AP. 2021. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M® membrane and excised human skin. Pharm Dev Technol. 26(2):243–251. doi: 10.1080/10837450.2020.1860087.
  • Nair RS, Billa N, Mooi LY, Morris AP. 2022. Characterization and ex vivo evaluation of curcumin nanoethosomes for melanoma treatment. Pharm Dev Technol. 27(1):72–82. doi: 10.1080/10837450.2021.2023568.
  • Narishetty ST, Panchagnula R. 2005. Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release. 102(1):59–70. doi: 10.1016/j.jconrel.2004.09.016.
  • Niu X-Q, Zhang D-P, Bian Q, Feng X-F, Li H, Rao Y-F, Shen Y-M, Geng F-N, Yuan A-R, Ying X-Y, et al. 2019. Mechanism investigation of ethosomes transdermal permeation. Int J Pharm X. 1:100027. doi: 10.1016/j.ijpx.2019.100027.
  • Obata Y, Ashitaka Y, Kikuchi S, Isowa K, Takayama K. 2010. A statistical approach to the development of a transdermal delivery system for ondansetron. Int J Pharm. 399(1–2):87–93. doi: 10.1016/j.ijpharm.2010.08.006.
  • Oh YK, Kim MY, Shin JY, Kim TW, Yun MO, Yang SJ, Choi SS, Jung WW, Kim JA, Choi HG. 2006. Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models. J Pharm Pharmacol. 58(2):161–166. doi: 10.1211/jpp.58.2.0002.
  • Rawat Singh M, Singh D, Saraf PS. 2011. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trends Medical Res. 6(2):101–115. doi: 10.3923/tmr.2011.101.115.
  • Rigg PC, Barry BW. 1990. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol. 94(2):235–240. doi: 10.1111/1523-1747.ep12874561.
  • Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. 2012. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 92:299–304. doi: 10.1016/j.colsurfb.2011.12.004.
  • Song YK, Kim CK. 2006. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 27(2):271–280. doi: 10.1016/j.biomaterials.2005.05.097.
  • Subongkot T, Duangjit S, Rojanarata T, Opanasopit P, Ngawhirunpat T. 2012. Ultradeformable liposomes with terpenes for delivery of hydrophilic compound. J Liposome Res. 22(3):254–262. doi: 10.3109/08982104.2012.690158.
  • Subongkot T, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2012. Effect of limonene and 1,8 cineole on the skin penetration of fluorescein sodium deformable liposomes. AMR. 506:449–452. doi: 10.4028/www.scientific.net/AMR.506.449.
  • Thakre A, Zore G, Kodgire S, Kazi R, Mulange S, Patil R, Shelar A, Santhakumari B, Kulkarni M, Kharat K, et al. 2018. Limonene inhibits Candida albicans growth by inducing apoptosis. Med Mycol. 56(5):565–578.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 65(3):403–418. doi: 10.1016/s0168-3659(99)00222-9.
  • Verma P, Pathak K. 2010. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 1(3):274–282. doi: 10.4103/0110-5558.72415.
  • Xu X, Khan MA, Burgess DJ. 2011. A quality by design (QbD) case study on liposomes containing hydrophilic API: i. Formulation, processing design and risk assessment. Int J Pharm. 419(1–2):52–59. doi: 10.1016/j.ijpharm.2011.07.012.
  • Yin F, Guo S, Gan Y, Zhang X. 2014. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor. Int J Nanomedicine. 9:1665–1676. doi: 10.2147/IJN.S59463.
  • Zaky AA. 2016. Comparative study of terbinafine hydrochloride transfersome, menthosome and ethosome novelvesicle formulation via skin penetration and antifungal efficacy. Az J Pharm Sci. 54:18–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.